Literature DB >> 2028299

Clinical long-term results of anterior discectomy without interbody fusion for cervical disc disease.

I Yamamoto1, A Ikeda, N Shibuya, R Tsugane, O Sato.   

Abstract

There were 55 patients (soft disc, 21 and spondylosis, 34) who underwent anterior cervical discectomy without fusion (ACD) using an operating microscope. Discectomy of a single level was performed on 48 cases and two levels on 7. There were 37 patients with radiculopathy, and 18 patients with myelopathy or myeloradiculopathy who were followed clinically for 2-13 years postoperatively. Overall 81% of patients were improved in soft disc herniation, and no significant differences were noted between the group of radiculopathy and myelopathy. In spondylosis all but one patient reported initial relief of their preoperative symptoms; however, overall improvement was noted in only 16 patients (47%). The causes of symptomatic deterioration after ACD for spondylosis were later symptomatic recurrence in 5 patients, severe neck pain in 4, and development of new symptoms due to adjacent spur formation in 2. The authors eventually added interbody fusion in 4 cases. Cervical spine roentgenograms almost always showed a loss of height of the interspace and an anterior angulation immediately after ACD, but the alignment of the spine tended to improve with time, so that, at last follow-up, 82% had a good alignment. A spontaneous osseous fusion occurred in 74% of cases. An adjacent spur formation was observed in 3 patients with spondylosis. The most troublesome complication was neck and/or scapular pain. This pain usually subsided spontaneously, but this continued for more than 4 years postoperatively in 4 patients with spondylosis. Using an operating microscope ACD is a safe and effective procedure for patients with soft disc herniation, but the authors still prefer anterior cervical discectomy with interbody fusion for the patients with advanced spondylosis.

Entities:  

Mesh:

Year:  1991        PMID: 2028299     DOI: 10.1097/00007632-199103000-00004

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  9 in total

1.  [HAC-titanium as an implant for interbody fusion in spinal canal stenosis of the cervical spine. Six-year clinical trial].

Authors:  D Daentzer; S Asamoto; D-K Böker
Journal:  Orthopade       Date:  2005-03       Impact factor: 1.087

2.  Microsurgical anterior decompression and internal fixation with iliac bone graft and titanium plates for treatment of cervical intervertebral disc herniation.

Authors:  M Muhlbauer; W Saringer; M Aichholzer; M Sunder-Plassmann
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 3.  Management of cervical spondylotic myelopathy and radiculopathy.

Authors:  R Braakman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-03       Impact factor: 10.154

4.  Results of anterior discectomy without fusion for treatment of cervical radiculopathy and myelopathy.

Authors:  S Tegos; K Rizos; A Papathanasiu; K Kyriakopulos
Journal:  Eur Spine J       Date:  1994       Impact factor: 3.134

5.  Is dysphonia permanent or temporary after anterior cervical approach?

Authors:  Serdar Kahraman; Sait Sirin; Ersin Erdogan; Cem Atabey; Mehmet Daneyemez; Engin Gonul
Journal:  Eur Spine J       Date:  2007-09-08       Impact factor: 3.134

6.  Iliac crest versus artificial bone grafts in 250 cervical fusions.

Authors:  S Savolainen; J P Usenius; J Hernesniemi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 7.  Cervical radiculopathy.

Authors:  Sravisht Iyer; Han Jo Kim
Journal:  Curr Rev Musculoskelet Med       Date:  2016-09

8.  Diagnostic imaging algorithm for cervical soft disc herniation.

Authors:  E Van de Kelft; M van Vyve
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

9.  Anterior discectomy without interbody fusion for cervical disc herniation.

Authors:  V Pointillart; A Cernier; J M Vital; J Senegas
Journal:  Eur Spine J       Date:  1995       Impact factor: 3.134

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.